4D Molecular Therapeutics FDMT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from 4D Molecular Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: 4D Molecular Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about 4D Molecular Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 4D Molecular Therapeutics's net margin?
- 4D Molecular Therapeutics (FDMT) reported net margin of -174,314.2% in Q3 2025.
- How has 4D Molecular Therapeutics's net margin changed year-over-year?
- 4D Molecular Therapeutics's net margin increased by 56.3% year-over-year, from -398,555.6% to -174,314.2%.
- What is the long-term trend for 4D Molecular Therapeutics's net margin?
- Over 4 years (2020 to 2024), 4D Molecular Therapeutics's net margin has grown at a 478.4% compound annual growth rate (CAGR), from -388.6% to -434,778.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.